SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-012734
Filing Date
2017-03-01
Accepted
2017-02-28 21:09:11
Documents
5
Period of Report
2017-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-7367_18k.htm 8-K 39740
2 EX-99.1 a17-7367_1ex99d1.htm EX-99.1 249073
3 EX-99.2 a17-7367_1ex99d2.htm EX-99.2 6962
4 GRAPHIC g73671mm01i001.jpg GRAPHIC 4985
5 GRAPHIC g73671moi001.gif GRAPHIC 6580
  Complete submission text file 0001104659-17-012734.txt   313298
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 17651104
SIC: 2834 Pharmaceutical Preparations